Arterial erectile dysfunction
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Male subjects aged 22 to 76 years with a stable partner (over 6 months); 2. ED subjects with unsatisfactory efficacy after treatment with PDE5i drugs; 3. Angiographic criteria: invasive DSA shows that ED-related arteries have >=50% stenosis, and the vessel diameter is >=2mm; 4. Voluntarily participate in this study and sign the informed consent.
Exclusion criteria
Exclusion criteria: 1. There is intolerance to antithrombotic drugs such as aspirin, clopidogrel, and heparin; 2. There are other uncorrected causes of ED, such as: hypogonadism, prostatectomy, pelvic injury, hormonal abnormalities, mental illness, drug-related factors, etc.; 3. Have severe cardiovascular and cerebrovascular diseases, have suffered myocardial infarction, angina pectoris, severe arrhythmia within 3 months before screening, or are receiving nitrate drug treatment; 4. There is >=50% obstructive stenosis in ED-related arteries with a diameter of less than 2 mm at the distal end of the target lesion; 5. Expected survival time < 12 months; 6. Those who are expected to have a birth plan within 6 months; 7. Other circumstances that the investigator considers inappropriate for inclusion.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Clinical success rate at 6 months after surgery; | — |
Secondary
| Measure | Time frame |
|---|---|
| Clinical success rate at 1 and 12 months after surgery;Target lesion restenosis rate confirmed by pelvic computed tomography at 8 months after surgery; | — |
Countries
China
Contacts
The First Affiliated Hospital, Sun Yat-Sen University